Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 15, 2011
Grant Date -
Apr 15, 2004
app pub date -
May 14, 2003
filing date -
Apr 20, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to the field glycosylation engineering of proteins. More particular, the present invention is directed to the glycosylation engineering of proteins to provide proteins with improved therapeutic properties, e.g., antibodies, antibody fragments, or a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin, with enhanced Fc-mediated cellular cytotoxicity.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully